Raised numbers of IgG4-positive plasma cells are a common histopathological finding in orbital xanthogranulomatous disease

Orbit. 2014 Feb;33(1):17-22. doi: 10.3109/01676830.2013.842252. Epub 2013 Oct 21.

Abstract

Purpose: To determine the relation of orbital xanthogranuloma with IgG4-related disease.

Methods: Retrospective consecutive case series over a period of 25 years. We searched our charts for histologically confirmed orbital xanthogranuloma. Patient files were reviewed for clinical and follow up data including presence or absence of systemic non-ophthalmic manifestations of IgG4 related disease. Slides were re-examined and histopathological classification was re-assessed. Sixteen cases of orbital xanthogranuloma were evaluated. Immunohistochemical stains for IgG and IgG4 were performed. Positive immunohistochemical staining required increased IgG4-positive plasma cells in the involved tissues scored as >50 per high-power field, with IgG4/IgG ratio >0.40.

Results: According to the criteria described above 8/16 (50%) cases showed increased numbers of IgG4-positive plasma cells in the specimens. Two of these patients may have had signs of systemic disease.

Conclusion: Raised numbers of IgG4-positive plasma cells are a common finding in histopathological specimens of xanthogranulomatous disease of the orbit and are often not indicative for IgG4 related systemic disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Follow-Up Studies
  • Granuloma / blood
  • Granuloma / diagnosis*
  • Humans
  • Immunoenzyme Techniques
  • Immunoglobulin G / blood*
  • Immunosuppressive Agents / therapeutic use
  • Lymphatic Diseases / blood
  • Lymphatic Diseases / pathology*
  • Male
  • Middle Aged
  • Orbital Diseases / blood
  • Orbital Diseases / diagnosis*
  • Plasma Cells / immunology
  • Plasma Cells / pathology*
  • Retrospective Studies
  • Xanthomatosis / blood
  • Xanthomatosis / diagnosis*

Substances

  • Immunoglobulin G
  • Immunosuppressive Agents